Skandinaviska Enskilda Banken (SEB)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,500
Closed -$3.86M 782
2025
Q3
$3.86M Sell
7,500
-51,497
-87% -$22.5M 0.02% 461
2025
Q2
$18.5M Sell
58,997
-84,900
-59% -$25.5M 0.08% 198
2025
Q1
$43.8M Sell
143,897
-25,800
-15% -$8.68M 0.22% 90
2024
Q4
$56.5M Buy
169,697
+9,948
+6% +$3.37M 0.26% 65
2024
Q3
$53.3M Buy
159,749
+19,900
+14% +$7.56M 0.25% 71
2024
Q2
$57.6M Buy
139,849
+50,302
+56% +$19.9M 0.28% 65
2024
Q1
$36.2M Buy
89,547
+53,789
+150% +$18.9M 0.18% 105
2023
Q4
$11M Buy
35,758
+7,800
+28% +$2.11M 0.06% 245
2023
Q3
$6.77M Sell
27,958
-2,000
-7% -$512K 0.04% 315
2023
Q2
$7.2M Buy
29,958
+21,700
+263% +$4.51M 0.05% 319
2023
Q1
$1.55M Buy
8,258
+1,542
+23% +$319K 0.01% 609
2022
Q4
$1.43M Sell
6,716
-388
-5% -$77.5K 0.01% 604
2022
Q3
$1.12M Sell
7,104
-4,403
-38% -$703K 0.01% 655
2022
Q2
$1.72M Sell
11,507
-1,340
-10% -$194K 0.01% 607
2022
Q1
$2.1M Sell
12,847
-2,436
-16% -$402K 0.01% 616
2021
Q4
$3.35M Buy
15,283
+1,760
+13% +$369K 0.02% 516
2021
Q3
$2.56M Sell
13,523
-740
-5% -$135K 0.01% 583
2021
Q2
$2.52M Sell
14,263
-8,338
-37% -$1.44M 0.02% 607
2021
Q1
$3.71M Sell
22,601
-2,118
-9% -$324K 0.02% 470
2020
Q4
$3.44M Sell
24,719
-2,353
-9% -$297K 0.02% 470
2020
Q3
$3.02M Buy
27,072
+617
+2% +$71.3K 0.02% 448
2020
Q2
$2.46M Buy
26,455
+755
+3% +$64.2K 0.02% 497
2020
Q1
$1.89M Sell
25,700
-5,000
-16% -$434K 0.02% 477
2019
Q4
$2.58M Buy
30,700
+1,900
+7% +$147K 0.02% 488
2019
Q3
$2.42M Sell
28,800
-12,400
-30% -$937K 0.02% 490
2019
Q2
$2.69M Sell
41,200
-4,900
-11% -$282K 0.02% 434
2019
Q1
$2.72M Sell
46,100
-5,800
-11% -$346K 0.02% 401
2018
Q4
$2.75M Sell
51,900
-9,100
-15% -$500K 0.02% 384
2018
Q3
$3.65M Buy
+61,000
New +$3.34M 0.03% 356

Other funds holding MEDP

Skandinaviska Enskilda Banken (SEB)'s MEDP Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Medpace (MEDP) in Q4 2025, closing a stake of 7,500 shares — an estimated $3.86M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MEDP in Q3 2018 and held it in 29 quarters. The position peaked at $57.6M in Q2 2024. 787 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 7,500 Medpace shares in Q4 2025, an estimated $3.86M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Medpace in Q3 2018 and held it in 29 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Medpace position peaked at $57.6M in Q2 2024.
  • 787 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.